Healthequity Stock In The News

Healthequity stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Healthequity earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Healthequity that is available to investors today. That information is available publicly through Healthequity media outlets and privately through word of mouth or via Healthequity internal channels. However, regardless of the origin, that massive amount of Healthequity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Healthequity news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Healthequity relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Healthequity's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Healthequity alpha.

Healthequity Largest EPS Surprises

Earnings surprises can significantly impact Healthequity's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-12-07
2015-10-310.070.080.0114 
2015-09-08
2015-07-310.080.090.0112 
2015-06-08
2015-04-300.090.10.0111 
2015-03-24
2015-01-310.030.040.0133 
2014-12-09
2014-10-310.040.050.0125 
2017-03-21
2017-01-310.06950.08920.019728 
View All Earnings Estimates

Healthequity Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Healthequity Stock. Current markets are strongly bearish. About 90% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News
27th of June 2022
Acquisition by Parker Stuart B of 2996 shares of Healthequity subject to Rule 16b-3
at MacroaxisInsider 
news
23rd of June 2022
Financial Statements
at SEC 
Investors Business Daily at Macroaxis
14th of June 2022
Big Fed Rate Hike Or Very Big Hike Market Awaits - Investors Business Daily
at www.investors.com 
Usa forbes News
8th of June 2022
UnitedHealth Groups Foundation Commits 100 Million To Health Equity And Diverse Workforce ...
at www.forbes.com 
news
6th of June 2022
EPS Reported
at EPS REPORTED 
news
23rd of May 2022
Pear Announces Health Equity Data Showing Similar Engagement with reSET-O Across US Geogra...
at www.marketscreener.com 
news
16th of May 2022
Financial Statements
at SEC 
news
13th of May 2022
New legislation calls on CMMI to create model based on health equity - FierceHealthcare
at www.fiercehealthcare.com 
news
4th of May 2022
Healthequity exotic insider transaction detected
at Natarajan Rajesh 
news
2nd of May 2022
Financial Statements
at SEC 
Macroaxis News
29th of April 2022
Acquisition by Parker Stuart B of 1212 shares of Healthequity subject to Rule 16b-3
at MacroaxisInsider 
news
27th of April 2022
EPS Estimate
at EPS ESTIMATE 
Yahoo News
25th of April 2022
Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved ...
at finance.yahoo.com 
news
14th of April 2022
Acquisition by Stephen Neeleman of 9535 shares of Healthequity subject to Rule 16b-3
at Stephen Neeleman 
news
5th of April 2022
Payment of 1025 shares by Murdock Tyson D of Healthequity subject to Rule 16b-3
at Murdock Tyson D 
news
4th of April 2022
Weve always had the answers Put underserved patients in the drivers seat to improve outcom...
at www.fiercehealthcare.com 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Healthequity Backtesting and Healthequity Hype Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.5 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
HQY
 Stock
  

USD 61.39  2.14  3.37%   

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Healthequity and other traded companies coverage. We help investors stay connected with Healthequity headlines for the 30th of June to make an informed investment decision based on correlating the impacts of news items on Healthequity Stock performance. Please note that trading solely based on the Healthequity hype is not for everyone as timely availability and quick action are needed to avoid losses. Net Income Common Stock is likely to drop to about (45.5 M) in 2022.
  
Refresh
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Healthequity headlines in addition to utilizing other, more conventional financial analysis modules. Please check Healthequity Backtesting and Healthequity Hype Analysis.
Healthequity's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Healthequity investors visualize upcoming and past events in order to time the market based on Healthequity noise-free hype analysis.